127 related articles for article (PubMed ID: 8933162)
1. Inhibition of LPS-induced tumor necrosis factor-alpha production by colchicine and other microtubule disrupting drugs.
Li Z; Davis GS; Mohr C; Nain M; Gemsa D
Immunobiology; 1996 Oct; 195(4-5):624-39. PubMed ID: 8933162
[TBL] [Abstract][Full Text] [Related]
2. Suppression of LPS-induced tumor necrosis factor-alpha gene expression by microtubule disrupting agents.
Li Z; Davis GS; Mohr C; Nain M; Gemsa D
Immunobiology; 1996 Oct; 195(4-5):640-54. PubMed ID: 8933163
[TBL] [Abstract][Full Text] [Related]
3. Colchicine has opposite effects on interleukin-1 beta and tumor necrosis factor-alpha production.
Allen JN; Herzyk DJ; Wewers MD
Am J Physiol; 1991 Oct; 261(4 Pt 1):L315-21. PubMed ID: 1928366
[TBL] [Abstract][Full Text] [Related]
4. Microtubule depolymerization selectively down-regulates the synthesis of proinflammatory secretory nonpancreatic phospholipase A2.
Pruzanski W; Kennedy BP; van den Bosch H; Stefanski E; Vadas P
Lab Invest; 1997 Feb; 76(2):171-8. PubMed ID: 9042153
[TBL] [Abstract][Full Text] [Related]
5. LPS-induced depolymerization of cytoskeleton and its role in TNF-alpha production by rat pneumocytes.
Isowa N; Xavier AM; Dziak E; Opas M; McRitchie DI; Slutsky AS; Keshavjee SH; Liu M
Am J Physiol; 1999 Sep; 277(3):L606-15. PubMed ID: 10484469
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies.
Delgado M; Pozo D; Martinez C; Leceta J; Calvo JR; Ganea D; Gomariz RP
J Immunol; 1999 Feb; 162(4):2358-67. PubMed ID: 9973516
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of tumor necrosis factor receptors on macrophages and endothelial cells by microtubule depolymerizing agents.
Ding AH; Porteu F; Sanchez E; Nathan CF
J Exp Med; 1990 Mar; 171(3):715-27. PubMed ID: 2155279
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma inhibits the suppressive effects of PGE2 on the production of tumor necrosis factor-alpha by mouse macrophages.
Kim JG; Hahn YS
Immunol Invest; 2000 Aug; 29(3):257-69. PubMed ID: 10933609
[TBL] [Abstract][Full Text] [Related]
9. Colchicine down-regulates lipopolysaccharide-induced granulocyte-macrophage colony-stimulating factor production in murine macrophages.
Rao P; Falk LA; Dougherty SF; Sawada T; Pluznik DH
J Immunol; 1997 Oct; 159(7):3531-9. PubMed ID: 9317152
[TBL] [Abstract][Full Text] [Related]
10. Regulation of macrophage-derived tumor necrosis factor production by modification of adrenergic receptor sensitivity.
Ignatowski TA; Spengler RN
J Neuroimmunol; 1995 Aug; 61(1):61-70. PubMed ID: 7560013
[TBL] [Abstract][Full Text] [Related]
11. Regulation of lipopolysaccharide-induced tumor necrosis factor alpha production by endogenous prostaglandin E2 in rat resident and thioglycollate-elicited macrophages.
Watanabe S; Kobayashi T; Okuyama H
J Lipid Mediat Cell Signal; 1994 Sep; 10(3):283-94. PubMed ID: 7812678
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel inhibitor of LPS-induced TNF-alpha production with antiproliferative activity in monocyte/macrophages.
Nagahira A; Nagahira K; Murafuji H; Abe K; Magota K; Matsui M; Oikawa S
Biochem Biophys Res Commun; 2001 Mar; 281(4):1030-6. PubMed ID: 11237767
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of 3,4-dichloro-propionaniline on cytokine production by macrophages is associated with LPS-mediated signal transduction.
Xie YC; Schafer R; Barnett JB
J Leukoc Biol; 1997 Jun; 61(6):745-52. PubMed ID: 9201266
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor.
Prabhakar U; Lipshutz D; Bartus JO; Slivjak MJ; Smith EF; Lee JC; Esser KM
Int J Immunopharmacol; 1994 Oct; 16(10):805-16. PubMed ID: 7843852
[TBL] [Abstract][Full Text] [Related]
15. Disruption of the interaction of alpha-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter.
Wersinger C; Sidhu A
Biochemistry; 2005 Oct; 44(41):13612-24. PubMed ID: 16216085
[TBL] [Abstract][Full Text] [Related]
16. Endotoxin tolerance impairs a pertussis-toxin-sensitive G-protein regulating tumour necrosis factor release by macrophages from tumour-bearing rats.
Altavilla D; Squadrito F; Canale P; Ioculano M; Campo GM; Squadrito G; Urna G; Sardella A; Caputi AP
Pharmacol Res; 1996 Mar; 33(3):203-9. PubMed ID: 8880892
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.
Galve-de Rochemonteix B; Nicod LP; Dayer JM
Am J Respir Cell Mol Biol; 1996 Mar; 14(3):279-87. PubMed ID: 8845179
[TBL] [Abstract][Full Text] [Related]
18. Microtubule-disrupting agents inhibit nitric oxide production in murine peritoneal macrophages stimulated with lipopolysaccharide or paclitaxel (Taxol).
Kirikae T; Kirikae F; Oghiso Y; Nakano M
Infect Immun; 1996 Aug; 64(8):3379-84. PubMed ID: 8757879
[TBL] [Abstract][Full Text] [Related]
19. Involvement of protein kinases in the potentiation of lipopolysaccharide-induced inflammatory mediator formation by thapsigargin in peritoneal macrophages.
Chen BC; Hsieh SL; Lin WW
J Leukoc Biol; 2001 Feb; 69(2):280-8. PubMed ID: 11272279
[TBL] [Abstract][Full Text] [Related]
20. Microtubule-active agents mimic lipopolysaccharides in priming macrophages for enhanced arachidonic acid metabolism.
Veis N; Rosen A; Aderem A
J Inflamm; 1996; 46(2):106-13. PubMed ID: 8734791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
